Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain

다국어 초록 (Multilingual Abstract)

Purpose The aim of this investigation was to formulate and evaluate naproxen transethosomal gel for sustained transdermal delivery for the management of musculoskeletal pain.
Methods In this examination naproxen sodium-loaded transethosomes were developed by ethanol injection method. A 9 run, 2-factor, 3-level factorial design was used to optimize naproxen-transethosomes. Transethosomal formulations were then incorporated into hydrogel made of gelling agent carbopol 940. The formulated transethosomes were characterized for particle size, entrapment efficiency, zeta potential, in-vitro release, ex-vivo drug permeation study, drug deposition study, and in-vivo anti-inflammatory study.
Results The results exhibited that the particle size were in the range of 56.94 ± 0.12 nm to 291.7 ± 0.09 nm. The transethosomes had higher entrapment efficiency in between 66.23 ± 1.52 and 93.11 ± 0.96% and exhibited a spherical morphology when examined by TEM analysis. The in-vitro skin permeation study carried out on rat skin exhibited enhanced skin deposition with lesser systemic absorption. The in-vivo studies carried out on rats showed the superiority of naproxen transethosomal gel in reducing the edema rate.
Conclusion The results obtained all together demonstrated that the formulated transethosomal gel possessed a smaller particle size, high entrapment efficiency along higher skin deposition rate which is required in getting relief from musculoskeletal pain. The developed formulation could be regarded as an ideal substitute for the conventional gel for the management of musculoskeletal pain.

참고문헌 (Reference)

1 Albash R, "Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil : in vitro, ex vivo, and in vivo evaluation" 14 : 1953-1968, 2019

2 Kumar A, "Ultra-adaptable nanovesicular systems : a carrier for systemic delivery of therapeutic agents" 17 : 1233-1241, 2012

3 Jain S, "Transfersomes—a novel vesicular carrier for enhanced transdermal delivery : development, characterization, and performance evaluation" 29 : 1013-1026, 2003

4 Cevc G, "Transfersomes, liposomes and other lipid suspensions on the skin : permeation enhancement, vesicle penetration, and transdermal drug delivery" 13 : 257-288, 1996

5 Gupta A, "Transfersomes : a novel vesicular carrier for enhanced transdermal delivery of sertraline : development, characterization, and performance evaluation" 80 : 1061-1080, 2012

6 Verma S, "Transethosomes of econazole nitrate for transdermal delivery : development, in-vitro characterization, and ex-vivo assessment" 6 : 171-179, 2018

7 Shaji J, "Transethosomes and ethosomes for enhanced transdermal delivery of ketorolac tromethamine : a comparative assessment" 6 : 88-93, 2014

8 Ibrahim MA, "Transethosomal gels as carriers for the transdermal delivery of colchicine : statistical optimization, characterization, and ex vivo evaluation" 12 : 795-813, 2018

9 Honeywell-Nguyen PL, "The in vitro transport of pergolide from surfactant based elastic vesicles through human skin : a suggested mechanism of action" 86 : 145-156, 2003

10 Li G, "Tacrolimus-loaded ethosomes : physicochemical characterization and in vivo evaluation" 82 : 49-57, 2012

11 Varun G, "Systematic development of transethosomal gel system of piroxicam : formulation optimization, in vitro evaluation, and ex vivo assessment" 18 : 58-71, 2017

12 Chen J, "Skin permeation behavior of elastic liposomes : role of formulation ingredients" 10 : 845-856, 2013

13 Chen M, "Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems : in vitro study with finite and infinite dosage application" 408 : 223-234, 2011

14 Chow LH, "Sex difference in oxytocin-induced anti-hyperalgesia at the spinal level in rats with intraplantar carrageenan-induced inflammation" 11 : 1-15, 2016

15 Lerma HC, "Segmented poly(urea)urethane nanoparticles : size optimization using Taguchi experimental design and nanoprecipitation method" 17 : 70-80, 2021

16 El-Zaafarany GM, "Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery" 397 : 164-172, 2010

17 Shreya Kaul, "Role of Nanotechnology in Cosmeceuticals: A Review of Recent Advances" Hindawi Limited 2018 : 1-19, 2018

18 El-Menshawe SF, "Preparation and optimization of buccal propranolol hydrochloride nanoethosomal gel : a novel approach for enhancement of bioavailability" 8 : 435-444, 2017

19 Sarwa KK, "Potential of capsaicin-loaded transfersomes in arthritic rats" 22 : 638-646, 2015

20 Bolzinger M, "Penetration of drugs through skin, a complex rate-controlling membrane" 17 : 156-165, 2012

21 Al-Shuwaili AH, "Optimization of elastic Transfersomes formulations for transdermal delivery of pentoxifylline" 102 : 101-114, 2016

22 Shariat A, "Office exercise training to reduce and prevent the occurrence of musculoskeletal disorders among office workers : a hypothesis" 23 : 54-58, 2016

23 Hiruta Y, "Novel ultradeformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin" 113 : 146-154, 2006

24 Aranya M, "Novel elastic nanovesicles for cosmeceutical and pharmaceutical applications" 36 : 168-178, 2009

25 Wright A, "Nonpharmacological treatments for musculoskeletal pain" 17 : 33-46, 2001

26 Al-Mahallawi AM, "Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery : in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment" 472 : 304-314, 2014

27 Jepps OG, "Modeling the human skin barrier–towards a better understanding of dermal absorption" 65 : 152-168, 2013

28 Kaul S, "Investigating the retention potential of chitosan nanoparticulate gel : design, development, in vitro & ex vivo characterization" 15 : 41-67, 2020

29 Rottke M, "In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions" 86 : 260-266, 2014

30 Azizah N, "In vitro penetration tests of transethosome gel preparations containing capsaicin" 9 : 116-119, 2017

31 Ramadon D, "In vitro penetration and bioavailability of novel transdermal quercetin-loaded ethosomal gel" 79 : 948-956, 2017

32 Zeb A, "Improved skin permeation of methotrexate via nanosized ultradeformable liposomes" 11 : 3813-3824, 2016

33 Romero EL, "Highly deformable and highly fluid vesicles as potential drug delivery systems : theoretical and practical considerations" 8 : 3171-3186, 2013

34 Shaji J, "Formulation development of 5-fluorouracil transethosomes for skin cancer therapy" 11 : 453-464, 2017

35 Gondkar SB, "Formulation development and characterization of drug loaded transethosomes for transdermal delivery : review article" 10 : 534-544, 2017

36 Tambade SA, "Formulation and evaluation of novel gel containing liquid crystals of naproxen" 2 : 364-386, 2014

37 Jain S, "Formulation and evaluation of ethosomes for transdermal delivery of lamivudine" 8 : 111-119, 2007

38 Kumar L, "Formulation and characterization of transethosomes for enhanced transdermal delivery of propranolol hydrochloride" 12 : 38-47, 2020

39 Chen ZX, "Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers" 99 : 240-245, 2017

40 Duangjit S, "Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers" 14 : 133-140, 2013

41 Dhawale T, "Evaluation of analgesic and anti-inflammatory activity of ibuprofen and duloxetine in animal models" 9 : 842-846, 2019

42 Touitou E, "Ethosomes—novel vesicular carriers for enhanced delivery : characterization and skin penetration properties" 65 : 403-418, 2000

43 Abdulbaqi IM, "Ethosomal nanocarriers : the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials" 25 : 2279-2304, 2016

44 Kumar L, "Ethanol based vesicular carriers in transdermal drug delivery : nanoethosomes and transethosomes in focus" 2 : 41-51, 2016

45 Saeed Ghanbarzadeh, "Enhanced Transdermal Delivery of Diclofenac Sodium via Conventional Liposomes, Ethosomes, and Transfersomes" Hindawi Limited 2013 : 1-7, 2013

46 Singh HP, "Elastic liposomal formulation for sustained delivery of colchicine : in vitro characterization and in vivo evaluation of anti-gout activity" 11 : 54-64, 2009

47 López-Pinto JM, "Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes" 298 : 1-12, 2005

48 Lei M, "Dual drug encapsulation in a novel nano-vesicular carrier for the treatment of cutaneous melanoma : characterization and in vitro/in vivo evaluation" 5 : 20467-20478, 2015

49 Wallace SJ, "Drug release from nanomedicines : selection of appropriate encapsulation and release methodology" 2 : 284-292, 2012

50 Ascenso A, "Development, characterization, and skin delivery studies of related ultradeformable vesicles : transfersomes, ethosomes, and transethosomes" 10 : 5837-5851, 2015

51 Moolakkadath T, "Development of transethosomes formulation for dermal fisetin delivery : Box-Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies" 46 : 755-765, 2018

52 Ricci M, "Development of liposomal capreomycin sulfate formulations : effects of formulation variables on peptide encapsulation" 311 : 172-181, 2006

53 Ma M, "Development of Nano vesicular systems for dermal imiquimod delivery : physicochemical characterization and in vitro/in vivo evaluation" 26 : 191-202, 2015

54 Abdelbary AA, "Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis : application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study" 485 : 235-243, 2015

55 Elsayed MS, "Deformable liposomes and ethosomes, mechanism of enhanced skin delivery" 322 : 60-66, 2006

56 Vinod KR, "Critical issues related to transfersomes-novel vesicular system" 11 : 67-82, 2012

57 Andega S, "Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin" 77 : 17-25, 2001

58 El-Alim SA, "Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal : in vitro and in vivo evaluation" 563 : 293-303, 2019

59 Vanić Ž, "Characterization of various deformable liposomes with metronidazole" 39 : 481-488, 2013

60 Bhatt P, "An in vitro assessment of thermo-reversible gel formulation containing sunitinib nanoparticles for neovascular age-related macular degeneration" 20 : 281-, 2019

61 Song CK, "A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole : characterization and in vitro/in vivo evaluation" 92 : 299-304, 2012